OMNISCAN

This brand name is authorized in Brazil, Canada, Cyprus, Estonia, Hong Kong, Croatia, Japan, Lithuania, New Zealand, Poland, Singapore, United States, South Africa

Active ingredients

The drug OMNISCAN contains one active pharmaceutical ingredient (API):

1 Gadodiamide UNII 84F6U3J2R6 - GADODIAMIDE

Gadodiamide is a paramagnetic contrast agent (GBCA), with imaging activity upon magnetic resonance imaging (MRI). Gadodiamide activity enhances the visualization of the tissues. Read about Gadodiamide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08CA03	Gadodiamide	V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 541613060001904, 541613060002004, 541613060002104
Country: CA	Health Products and Food Branch	Identifier(s): 02172771
Country: EE	Ravimiamet	Identifier(s): 1005871, 1079513, 1079524, 1079535, 1151569, 1151570, 1626342
Country: HK	Department of Health Drug Office	Identifier(s): 43493
Country: JP	医薬品医療機器総合機構	Identifier(s): 7290408A1036, 7290408G1039, 7290408G2035, 7290408G3031, 7290408G4038
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008753, 1008754, 1008755, 1008756, 1071660
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6848
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100049523
Country: SG	Health Sciences Authority	Identifier(s): 08521P
Country: US	FDA, National Drug Code	Identifier(s): 0407-0690, 0407-0691
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/28/0563, 29/28/0564, 29/28/0565, 30/28/0159